{
  "name": "pharmacy_copilot_pharmacist_eval_v1",
  "description": "Gold pharmacist scenarios for LLM evaluation (enriched for deterministic scoring).",
  "version": "1.2.0",
  "questions": [
    {
      "id": "q001",
      "question": "5-year-old (18 kg) with acute otitis media. What is the amoxicillin dose and volume using 400 mg/5 mL suspension?",
      "question_type": "dosage",
      "difficulty": "medium",
      "expected_answer": "Amoxicillin 90 mg/kg/day divided q12h \u2192 810 mg per dose (\u224810.1 mL of 400 mg/5 mL), round to 10 mL per dose; max 4 g/day.",
      "answer_key_points": [
        "Uses high-dose 80\u201390 mg/kg/day regimen",
        "BID (q12h) frequency",
        "Per-dose \u2248810 mg for 18 kg",
        "Volume \u224810.1 mL from 400 mg/5 mL (80 mg/mL); rounding to 10 mL OK",
        "Max daily 4 g acknowledged",
        "No renal adjustment if normal function",
        "Cites pediatric dosage section"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-amoxicillin-2018#dosage",
          "relevance_score": 1.0,
          "is_essential": true
        },
        {
          "chunk_id": "lexi-amoxicillin-2018#peds",
          "relevance_score": 1.0,
          "is_essential": false
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-amoxicillin-2018#dosage",
          "role": "support",
          "text": "Pediatric AOM first-line: amoxicillin 80–90 mg/kg/day PO divided q12h for 5–10 days; typical max daily dose ~4,000 mg."
        },
        {
          "chunk_id": "lexi-amoxicillin-2018#peds",
          "role": "support",
          "text": "Amoxicillin oral suspension 400 mg/5 mL = 80 mg/mL; use oral syringe; rounding to practical mL is acceptable."
        },
        {
          "chunk_id": "lexi-amoxicillin-2018#adult-sinusitis",
          "role": "distractor",
          "text": "Adult acute bacterial sinusitis regimens (e.g., 500 mg TID or 875 mg BID) differ from pediatric AOM dosing."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": [
          "lexi-amoxicillin-2018#dosage",
          "lexi-amoxicillin-2018#peds"
        ],
        "disallowed_chunk_ids": ["lexi-amoxicillin-2018#adult-sinusitis"]
      },
      "drug_names": ["amoxicillin"],
      "tags": ["dosage"],
      "gold": {
        "dose_per_dose_mg": 810,
        "doses_per_day": 2,
        "total_daily_mg": 1620,
        "calc_rule": "90 mg/kg/day divided q12h",
        "max_daily_mg": 4000,
        "volume_per_dose_mL": 10.125,
        "rounding": {
          "to": "10 mL per dose",
          "basis": "80 mg/mL (400 mg/5 mL)"
        },
        "renal_adjustment": "none if normal renal function",
        "hepatic_adjustment": "none specified",
        "contraindications": [],
        "interactions": [],
        "recency_risk": false,
        "citations": [
          "lexi-amoxicillin-2018#dosage",
          "lexi-amoxicillin-2018#peds"
        ]
      }
    },
    {
      "id": "q002",
      "question": "12 kg child with fever: acetaminophen dose and volume using 160 mg/5 mL?",
      "question_type": "dosage",
      "difficulty": "medium",
      "expected_answer": "Acetaminophen 15 mg/kg/dose q6h (range 10\u201315 mg/kg q4\u20136h) \u2192 180 mg per dose \u22485.6 mL of 160 mg/5 mL; max 75 mg/kg/day (900 mg), and \u22644 g absolute.",
      "answer_key_points": [
        "Per-dose 15 mg/kg used",
        "q4\u20136h acceptable; target q6h in calc",
        "180 mg per dose for 12 kg",
        "Volume \u22485.625 mL from 32 mg/mL",
        "Daily max 75 mg/kg/day and \u22644 g",
        "Pediatric dosing section cited"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-acetaminophen-2018#peds-dosing",
          "relevance_score": 1.0,
          "is_essential": true
        },
        {
          "chunk_id": "lexi-acetaminophen-2018#max",
          "relevance_score": 1.0,
          "is_essential": false
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-acetaminophen-2018#peds-dosing",
          "role": "support",
          "text": "Acetaminophen 10–15 mg/kg/dose PO q4–6h PRN fever/pain; do not exceed 75 mg/kg/day or 4,000 mg/day; ~5 doses/24h."
        },
        {
          "chunk_id": "lexi-acetaminophen-2018#max",
          "role": "support",
          "text": "Common liquid: 160 mg/5 mL (32 mg/mL). Use weight-based dosing and state per-dose mL."
        },
        {
          "chunk_id": "lexi-acetaminophen-2018#rectal",
          "role": "distractor",
          "text": "Rectal suppository dosing differs from oral liquids and is not used for this calculation."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": [
          "lexi-acetaminophen-2018#peds-dosing",
          "lexi-acetaminophen-2018#max"
        ],
        "disallowed_chunk_ids": ["lexi-acetaminophen-2018#rectal"]
      },
      "drug_names": ["acetaminophen"],
      "tags": ["dosage"],
      "gold": {
        "dose_per_dose_mg": 180,
        "doses_per_day": 4,
        "total_daily_mg": 720,
        "calc_rule": "15 mg/kg/dose q6h (10\u201315 mg/kg q4\u20136h acceptable)",
        "max_daily_mg": 900,
        "volume_per_dose_mL": 5.625,
        "rounding": {
          "to": "5.6 mL",
          "basis": "32 mg/mL (160 mg/5 mL)"
        },
        "renal_adjustment": "none for standard antipyresis",
        "hepatic_adjustment": "use caution in hepatic impairment",
        "contraindications": [],
        "interactions": [],
        "recency_risk": false,
        "citations": [
          "lexi-acetaminophen-2018#peds-dosing",
          "lexi-acetaminophen-2018#max"
        ]
      }
    },
    {
      "id": "q003",
      "question": "12 kg child with fever: ibuprofen dose and volume using 100 mg/5 mL?",
      "question_type": "dosage",
      "difficulty": "medium",
      "expected_answer": "Ibuprofen 10 mg/kg/dose q6\u20138h \u2192 120 mg per dose (6 mL of 100 mg/5 mL); max 40 mg/kg/day (480 mg). Avoid if <6 months or dehydrated/renal issues.",
      "answer_key_points": [
        "10 mg/kg per dose",
        "q6\u20138h frequency",
        "120 mg per dose for 12 kg",
        "6 mL at 20 mg/mL",
        "Max 40 mg/kg/day (480 mg)",
        "Contraindication: <6 months; caution renal/dehydration"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-ibuprofen-2018#peds-dosing",
          "relevance_score": 1.0,
          "is_essential": true
        },
        {
          "chunk_id": "lexi-ibuprofen-2018#max",
          "relevance_score": 1.0,
          "is_essential": false
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-ibuprofen-2018#peds-dosing",
          "role": "support",
          "text": "Ibuprofen 10 mg/kg/dose PO q6–8h PRN; maximum 40 mg/kg/day; avoid in dehydration or significant renal risk."
        },
        {
          "chunk_id": "lexi-ibuprofen-2018#max",
          "role": "support",
          "text": "Oral suspension 100 mg/5 mL (20 mg/mL); compute per-dose mL from weight-based mg."
        },
        {
          "chunk_id": "lexi-ibuprofen-2018#adult-capsules",
          "role": "distractor",
          "text": "Adult OTC capsule labeling (200 mg) is not applicable to pediatric suspension dosing."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": [
          "lexi-ibuprofen-2018#peds-dosing",
          "lexi-ibuprofen-2018#max"
        ],
        "disallowed_chunk_ids": ["lexi-ibuprofen-2018#adult-capsules"]
      },
      "drug_names": ["ibuprofen"],
      "tags": ["dosage"],
      "gold": {
        "dose_per_dose_mg": 120,
        "doses_per_day": 4,
        "total_daily_mg": 480,
        "calc_rule": "10 mg/kg/dose q6\u20138h; max 40 mg/kg/day",
        "max_daily_mg": 480,
        "volume_per_dose_mL": 6.0,
        "rounding": {
          "to": "6 mL",
          "basis": "20 mg/mL (100 mg/5 mL)"
        },
        "renal_adjustment": "avoid in significant renal impairment/dehydration",
        "hepatic_adjustment": "use caution",
        "contraindications": ["<6 months age", "active GI bleed"],
        "interactions": [],
        "recency_risk": false,
        "citations": [
          "lexi-ibuprofen-2018#peds-dosing",
          "lexi-ibuprofen-2018#max"
        ]
      }
    },
    {
      "id": "q004",
      "question": "Elderly patient with nonvalvular AF: 82 years, 58 kg, SCr 1.6 mg/dL. What apixaban dose?",
      "question_type": "dosage",
      "difficulty": "medium",
      "expected_answer": "Apixaban 2.5 mg BID (meets 2 of 3: age \u226580, weight \u226460 kg, SCr \u22651.5). Avoid with strong CYP3A4/P-gp inhibitors.",
      "answer_key_points": [
        "Dose reduction criteria (2 of 3)",
        "Final dose 2.5 mg BID",
        "Interaction caveat: strong CYP3A4/P-gp",
        "Hepatic impairment caution"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-apixaban-2018#dosing-nvaf",
          "relevance_score": 1.0,
          "is_essential": true
        },
        {
          "chunk_id": "lexi-apixaban-2018#ddi",
          "relevance_score": 1.0,
          "is_essential": false
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-apixaban-2018#dosing-nvaf",
          "role": "support",
          "text": "NVAF: apixaban 5 mg BID; reduce to 2.5 mg BID if the patient has ≥2 of: age ≥80 years, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL."
        },
        {
          "chunk_id": "lexi-apixaban-2018#ddi",
          "role": "support",
          "text": "Avoid with strong dual CYP3A4/P-gp inhibitors/inducers; assess hepatic impairment."
        },
        {
          "chunk_id": "lexi-apixaban-2018#vte",
          "role": "distractor",
          "text": "VTE treatment: 10 mg BID x7 days then 5 mg BID—this regimen does not apply to NVAF dosing decisions."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": [
          "lexi-apixaban-2018#dosing-nvaf",
          "lexi-apixaban-2018#ddi"
        ],
        "disallowed_chunk_ids": ["lexi-apixaban-2018#vte"]
      },
      "drug_names": ["apixaban"],
      "tags": ["dosage"],
      "gold": {
        "dose_per_dose_mg": 2.5,
        "doses_per_day": 2,
        "total_daily_mg": 5,
        "calc_rule": "If \u22652 of {age \u226580, weight \u226460 kg, SCr \u22651.5} \u2192 2.5 mg BID",
        "max_daily_mg": 10,
        "renal_adjustment": "criteria-based reduction as above",
        "hepatic_adjustment": "avoid in severe hepatic impairment",
        "contraindications": ["active bleeding"],
        "interactions": [
          {
            "drug": "strong CYP3A4/P-gp inhibitors",
            "severity": "major",
            "action": "avoid or reduce/monitor"
          }
        ],
        "recency_risk": false,
        "citations": [
          "lexi-apixaban-2018#dosing-nvaf",
          "lexi-apixaban-2018#ddi"
        ]
      }
    },
    {
      "id": "q005",
      "question": "85 kg adult with acute DVT: What is the enoxaparin treatment dose (normal renal function)?",
      "question_type": "dosage",
      "difficulty": "medium",
      "expected_answer": "Enoxaparin 1 mg/kg SC q12h \u2192 85 mg per dose (or 1.5 mg/kg once daily as alternative). If CrCl <30 mL/min: 1 mg/kg once daily.",
      "answer_key_points": [
        "1 mg/kg q12h primary regimen",
        "Alternative 1.5 mg/kg q24h",
        "Per-dose 85 mg for 85 kg",
        "Renal adjustment for CrCl <30"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-enoxaparin-2018#dosing",
          "relevance_score": 1.0,
          "is_essential": true
        },
        {
          "chunk_id": "lexi-enoxaparin-2018#renal",
          "relevance_score": 1.0,
          "is_essential": false
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-enoxaparin-2018#dosing",
          "role": "support",
          "text": "Acute DVT treatment (normal renal function): enoxaparin 1 mg/kg SC q12h (preferred) or 1.5 mg/kg SC once daily (alternative)."
        },
        {
          "chunk_id": "lexi-enoxaparin-2018#renal",
          "role": "support",
          "text": "If CrCl <30 mL/min, use 1 mg/kg SC once daily and monitor anti-Xa as indicated."
        },
        {
          "chunk_id": "lexi-enoxaparin-2018#prophylaxis",
          "role": "distractor",
          "text": "VTE prophylaxis doses (e.g., 40 mg SC daily) are not treatment doses and should not be used here."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": [
          "lexi-enoxaparin-2018#dosing",
          "lexi-enoxaparin-2018#renal"
        ],
        "disallowed_chunk_ids": ["lexi-enoxaparin-2018#prophylaxis"]
      },

      "drug_names": ["enoxaparin"],
      "tags": ["dosage"],
      "gold": {
        "dose_per_dose_mg": 85,
        "doses_per_day": 2,
        "total_daily_mg": 170,
        "calc_rule": "1 mg/kg q12h (or 1.5 mg/kg q24h alternative)",
        "max_daily_mg": null,
        "renal_adjustment": "CrCl <30: 1 mg/kg once daily",
        "hepatic_adjustment": "use caution",
        "contraindications": [
          "active major bleeding",
          "history of HIT (use alternative)"
        ],
        "interactions": [],
        "recency_risk": false,
        "citations": [
          "lexi-enoxaparin-2018#dosing",
          "lexi-enoxaparin-2018#renal"
        ]
      }
    },
    {
      "id": "q006",
      "question": "Type 2 diabetes patient with eGFR 28 mL/min/1.73 m\u00b2. Can we use metformin?",
      "question_type": "dosage",
      "difficulty": "medium",
      "expected_answer": "No\u2014contraindicated at eGFR <30. If 30\u201345, generally avoid initiation; if continuing, reduce dose and monitor. Avoid in hepatic impairment.",
      "answer_key_points": [
        "Contraindicated if eGFR <30",
        "30\u201345: avoid initiation; if continuing, reduce & monitor",
        "Hepatic impairment: avoid (lactic acidosis risk)"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-metformin-2018#renal",
          "relevance_score": 1.0,
          "is_essential": true
        },
        {
          "chunk_id": "lexi-metformin-2018#contra",
          "relevance_score": 1.0,
          "is_essential": false
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-metformin-2018#renal",
          "role": "support",
          "text": "Metformin: contraindicated if eGFR <30 mL/min/1.73 m². At 30–45, generally avoid initiation; if continuing, reduce dose and monitor renal function."
        },
        {
          "chunk_id": "lexi-metformin-2018#contra",
          "role": "support",
          "text": "Avoid in hepatic impairment or conditions predisposing to lactic acidosis; manage iodinated contrast per eGFR."
        },
        {
          "chunk_id": "lexi-metformin-2018#old-crcl60",
          "role": "distractor",
          "text": "Older conservative thresholds (e.g., avoid if CrCl <60) are superseded by eGFR-based guidance."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": [
          "lexi-metformin-2018#renal",
          "lexi-metformin-2018#contra"
        ],
        "disallowed_chunk_ids": ["lexi-metformin-2018#old-crcl60"]
      },
      "drug_names": ["metformin"],
      "tags": ["dosage"],
      "gold": {
        "decision": "contraindicated",
        "calc_rule": "eGFR <30 \u2192 do not initiate/continue",
        "renal_adjustment": "eGFR 30\u201345: avoid initiation; reduce if continuing; monitor",
        "hepatic_adjustment": "avoid in hepatic impairment",
        "contraindications": ["eGFR <30", "acute/chronic metabolic acidosis"],
        "interactions": [
          {
            "drug": "iodinated contrast",
            "severity": "major",
            "action": "hold around procedure per eGFR"
          }
        ],
        "recency_risk": false,
        "citations": ["lexi-metformin-2018#renal", "lexi-metformin-2018#contra"]
      }
    },
    {
      "id": "q007",
      "question": "Uncomplicated cystitis: Should we use nitrofurantoin if eGFR is 25?",
      "question_type": "dosage",
      "difficulty": "medium",
      "expected_answer": "Avoid nitrofurantoin when eGFR/CrCl <30 mL/min due to low urinary levels and toxicity risk.",
      "answer_key_points": [
        "Avoid if eGFR/CrCl <30",
        "Rationale: efficacy/toxicity",
        "List common contraindications where relevant"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-nitrofurantoin-2018#renal",
          "relevance_score": 1.0,
          "is_essential": true
        },
        {
          "chunk_id": "lexi-nitrofurantoin-2018#contra",
          "relevance_score": 1.0,
          "is_essential": false
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-nitrofurantoin-2018#renal",
          "role": "support",
          "text": "Nitrofurantoin: avoid when eGFR/CrCl <30 mL/min due to inadequate urinary concentrations and increased toxicity risk."
        },
        {
          "chunk_id": "lexi-nitrofurantoin-2018#contra",
          "role": "support",
          "text": "Contraindications include late-term pregnancy (at term) and significant renal dysfunction."
        },
        {
          "chunk_id": "lexi-nitrofurantoin-2018#prophylaxis",
          "role": "distractor",
          "text": "Prophylaxis regimens (e.g., low-dose at bedtime) do not override renal cutoffs for acute cystitis treatment."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": [
          "lexi-nitrofurantoin-2018#renal",
          "lexi-nitrofurantoin-2018#contra"
        ],
        "disallowed_chunk_ids": ["lexi-nitrofurantoin-2018#prophylaxis"]
      },
      "drug_names": ["nitrofurantoin"],
      "tags": ["dosage"],
      "gold": {
        "decision": "avoid",
        "calc_rule": "Avoid if eGFR/CrCl <30",
        "renal_adjustment": "not recommended below threshold",
        "hepatic_adjustment": "use caution",
        "contraindications": ["CrCl <30", "late-term pregnancy (at term)"],
        "interactions": [],
        "recency_risk": false,
        "citations": [
          "lexi-nitrofurantoin-2018#renal",
          "lexi-nitrofurantoin-2018#contra"
        ]
      }
    },
    {
      "id": "q008",
      "question": "Patient on warfarin needs TMP-SMX for UTI. Any interaction and what should we do?",
      "question_type": "interaction",
      "difficulty": "medium",
      "expected_answer": "Major interaction (CYP2C9 inhibition + gut flora). Avoid if possible; otherwise increase INR monitoring and reduce warfarin dose.",
      "answer_key_points": [
        "Mechanism: CYP2C9 inhibition + gut flora",
        "Severity: major",
        "Action: avoid or close INR monitoring with dose reduction"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-warfarin-2018#ddi-tmp-smx",
          "relevance_score": 1.0,
          "is_essential": true
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-warfarin-2018#ddi-tmp-smx",
          "role": "support",
          "text": "TMP-SMX markedly increases warfarin effect via CYP2C9 inhibition and gut-flora changes; expect INR rise. Prefer alternatives; if used, reduce warfarin dose and increase INR monitoring."
        },
        {
          "chunk_id": "lexi-warfarin-2018#ddi-cephalexin",
          "role": "distractor",
          "text": "Cephalexin has minimal effect on warfarin relative to TMP-SMX; management differs."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": ["lexi-warfarin-2018#ddi-tmp-smx"],
        "disallowed_chunk_ids": ["lexi-warfarin-2018#ddi-cephalexin"]
      },
      "drug_names": ["warfarin"],
      "tags": ["interaction"],
      "gold": {
        "interactions": [
          {
            "drug": "trimethoprim/sulfamethoxazole",
            "mechanism": "CYP2C9 inhibition + gut flora change",
            "severity": "major",
            "action": "avoid if possible; otherwise increase INR monitoring and reduce warfarin dose"
          }
        ],
        "contraindications": [],
        "recency_risk": false,
        "citations": ["lexi-warfarin-2018#ddi-tmp-smx"]
      }
    },
    {
      "id": "q009",
      "question": "Patient on atorvastatin needs clarithromycin. What\u2019s the risk and action?",
      "question_type": "interaction",
      "difficulty": "medium",
      "expected_answer": "Major interaction (strong CYP3A4 inhibitor). Avoid coadministration; if unavoidable, hold atorvastatin or limit to the lowest dose and monitor for myopathy.",
      "answer_key_points": [
        "Mechanism: strong CYP3A4 inhibition",
        "Severity: major",
        "Action: avoid; if unavoidable hold or use lowest dose with monitoring"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-atorvastatin-2018#ddi-macrolides",
          "relevance_score": 1.0,
          "is_essential": true
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-atorvastatin-2018#ddi-macrolides",
          "role": "support",
          "text": "Clarithromycin is a strong CYP3A4 inhibitor; coadministration increases atorvastatin levels and myopathy/rhabdomyolysis risk. Avoid; if unavoidable, hold or use the lowest dose with close monitoring."
        },
        {
          "chunk_id": "lexi-atorvastatin-2018#ddi-azithro",
          "role": "distractor",
          "text": "Azithromycin has little CYP3A4 inhibition and is not a suitable proxy for clarithromycin interactions."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": ["lexi-atorvastatin-2018#ddi-macrolides"],
        "disallowed_chunk_ids": ["lexi-atorvastatin-2018#ddi-azithro"]
      },
      "drug_names": ["atorvastatin"],
      "tags": ["interaction"],
      "gold": {
        "interactions": [
          {
            "drug": "clarithromycin",
            "mechanism": "strong CYP3A4 inhibition",
            "severity": "major",
            "action": "avoid coadministration; if unavoidable, hold atorvastatin or use lowest dose with monitoring"
          }
        ],
        "contraindications": [],
        "recency_risk": false,
        "citations": ["lexi-atorvastatin-2018#ddi-macrolides"]
      }
    },
    {
      "id": "q010",
      "question": "Starting linezolid in a patient on sertraline. Is this safe?",
      "question_type": "interaction",
      "difficulty": "medium",
      "expected_answer": "Major interaction: risk of serotonin syndrome (linezolid has MAOI activity). Avoid; if benefits outweigh risks, withhold SSRI or monitor very closely.",
      "answer_key_points": [
        "Mechanism: MAOI activity \u2192 \u2191serotonin",
        "Severity: major",
        "Action: avoid; or stop SSRI/close monitoring if unavoidable"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-linezolid-2018#ddi-ssri",
          "relevance_score": 1.0,
          "is_essential": true
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-linezolid-2018#ddi-ssri",
          "role": "support",
          "text": "Linezolid has reversible MAOI activity and may precipitate serotonin syndrome with SSRIs. Avoid combination; if benefits outweigh risks, withhold SSRI and monitor closely."
        },
        {
          "chunk_id": "lexi-linezolid-2018#ddi-penicillins",
          "role": "distractor",
          "text": "No serotonergic interaction with penicillins; this is not relevant to SSRI risk."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": ["lexi-linezolid-2018#ddi-ssri"],
        "disallowed_chunk_ids": ["lexi-linezolid-2018#ddi-penicillins"]
      },
      "drug_names": ["linezolid"],
      "tags": ["interaction"],
      "gold": {
        "interactions": [
          {
            "drug": "sertraline (SSRI)",
            "mechanism": "MAOI activity of linezolid \u2192 \u2191serotonin",
            "severity": "major",
            "action": "avoid combination; if unavoidable, withhold SSRI or monitor closely"
          }
        ],
        "contraindications": [],
        "recency_risk": false,
        "citations": ["lexi-linezolid-2018#ddi-ssri"]
      }
    },
    {
      "id": "q011",
      "question": "Patient on digoxin will start amiodarone. What\u2019s the interaction management?",
      "question_type": "interaction",
      "difficulty": "medium",
      "expected_answer": "Major interaction (P-gp inhibition). Reduce digoxin dose by ~30\u201350% and monitor levels/ECG.",
      "answer_key_points": [
        "Mechanism: P-gp inhibition \u2192 \u2191digoxin",
        "Severity: major",
        "Action: reduce dose ~30\u201350% + monitor levels and ECG"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-digoxin-2018#ddi-amio",
          "relevance_score": 1.0,
          "is_essential": true
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-digoxin-2018#ddi-amio",
          "role": "support",
          "text": "Amiodarone inhibits P-gp, increasing digoxin exposure. Reduce digoxin dose by ~30–50% and monitor serum levels, renal function, and ECG."
        },
        {
          "chunk_id": "lexi-digoxin-2018#ddi-verapamil",
          "role": "distractor",
          "text": "Verapamil also raises digoxin via P-gp inhibition, but this does not address amiodarone-specific management."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": ["lexi-digoxin-2018#ddi-amio"],
        "disallowed_chunk_ids": ["lexi-digoxin-2018#ddi-verapamil"]
      },
      "drug_names": ["digoxin"],
      "tags": ["interaction"],
      "gold": {
        "interactions": [
          {
            "drug": "amiodarone",
            "mechanism": "P-gp inhibition \u2192 \u2191digoxin levels",
            "severity": "major",
            "action": "reduce digoxin dose by ~30\u201350% and monitor serum levels and ECG"
          }
        ],
        "contraindications": [],
        "recency_risk": false,
        "citations": ["lexi-digoxin-2018#ddi-amio"]
      }
    },
    {
      "id": "q012",
      "question": "COVID-19 patient asks for Paxlovid dosing and interaction checks.",
      "question_type": "dosage",
      "difficulty": "medium",
      "expected_answer": "ABSTAIN. Not in \u22642018 corpus; recency-sensitive therapy. Advise consulting current guidance/pharmacist.",
      "answer_key_points": [
        "Explicit abstention",
        "Sets recency_risk = true",
        "Advises pharmacist/current guidance"
      ],
      "relevant_chunks": [],
      "oracle_context": [
        {
          "chunk_id": "kb-scope-2018#covid-absent",
          "role": "support",
          "text": "The corpus predates COVID-19 therapies (e.g., nirmatrelvir/ritonavir). This is recency-sensitive; abstain and refer to current guidance/pharmacist."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": ["kb-scope-2018#covid-absent"],
        "disallowed_chunk_ids": []
      },
      "drug_names": ["nirmatrelvir/ritonavir (Paxlovid)"],
      "tags": ["dosage"],
      "gold": {
        "abstain_expected": true,
        "reason": "Not present in \u22642018 corpus; recency-sensitive",
        "recency_risk": true,
        "citations": []
      }
    },
    {
      "id": "q013",
      "question": "What is the current first-line pharmacologic therapy per latest hypertension guidelines?",
      "question_type": "guideline",
      "difficulty": "medium",
      "expected_answer": "ABSTAIN if asked for \u2018current\u2019 guidance (2018 corpus includes JNC8/2014). Flag recency risk.",
      "answer_key_points": [
        "Explicit abstention for \u2018current\u2019 guideline ask",
        "Recognize JNC8 (2014) is outdated for \u2018current\u2019",
        "Sets recency_risk = true"
      ],
      "relevant_chunks": [
        {
          "chunk_id": "lexi-hypertension-2014#jnc8",
          "relevance_score": 1.0,
          "is_essential": true
        }
      ],
      "oracle_context": [
        {
          "chunk_id": "lexi-hypertension-2014#jnc8",
          "role": "support",
          "text": "Corpus contains JNC8 (2014) content. If the question asks for the *current* guideline, abstain and flag recency risk rather than quoting outdated recommendations."
        }
      ],
      "judge_metadata": {
        "allowed_chunk_ids": ["lexi-hypertension-2014#jnc8"],
        "disallowed_chunk_ids": []
      },
      "drug_names": [],
      "tags": ["guideline"],
      "gold": {
        "abstain_expected": true,
        "reason": "Question seeks guidance newer than 2018; corpus includes JNC8 (2014) only",
        "recency_risk": true,
        "citations": ["lexi-hypertension-2014#jnc8"]
      }
    }
  ]
}
